Cytokine profile in murine toxoplasmosis

Asian Pacific Journal of Tropical Medicine

Volumn 4, Issue 1, 2011, Pages 16-19

  Dogruman Al, Funda ^a   Fidan, Isil ^a   Celebi, Bekir ^b   Yesilyurt, Emine ^a   Erdal, Berna ^a   Babur, Cahit ^b   Kustimur, Semra ^a  

^a Department of Microbiology and Clinical Microbiology   (Turkey)

^b Refik Saydam Hygiene Center   (Turkey)

Author keywords

Cytokine; Murine toxoplasmosis; Pathogenesis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPATHOGENESIS; MALE; MOUSE; NONHUMAN; PARASITE VIRULENCE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MICE; SERUM; TH1 CELLS; TOXOPLASMA; TOXOPLASMOSIS;

EID: 78651462646     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(11)60024-2     Document Type: Article

References (26)

1. Remington JS, McLeod R, Thulliez P, Desmonts G Toxoplasmosis. Infection diseases of the fetus and newborn infant 2001, W. B. Saunders, Philadelphia. J.S. Remington, O.J. Klein (Eds.).
2. Filisetti D, Candolfi E Immune response to Toxoplasma gondii. Ann Ist Super Sanità 2004, 40:71-80.
3. Gaddi PJ, Yap GS Cytokine regulation of immunopathology in toxoplasmosis. Immun Cell Biol 2007, 85:155-159.
4. Bhopale GM Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 2003, 26:213-222.
5. Aliberti J Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii. Nat Rev Immunol 2005, 5:162-170.
6. Barbosa BF, Silva DAO, Costa IN, Mineo JR, Ferro EAV BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon-γ, interleukin-10 and transforming growth factor-β1. Clin Exp Immunol 2008, 151:536-545.
7. Yano A, Mun HS, Chin M, Norose K, Hata K, Kobayashi M, et al. Roles of IFN-gama on stage conversion of an obligate intracellular protozoan parasite, Toxoplasma gondii. Int Rev Immunol 2002, 21:405-421.
8. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 1996, 157:798-805.
9. Gavrilescu LC, Denkers EY IFN-γ overproduction and high level apoptosis are associated with high but not low virulence Toxoplasma gondii infection. J Immunol 2001, 167:902-909.
10. Nguyen TD, Bigaignon G, Markine-Goriaynoff D, Uyttenhove C, Van Snick J, Coutelier JP, et al. Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and γ-interferon. J Med Microbiol 2003, 52:869-876.
11. Calabrase KS, Tedesco RC, Zaverucha do Valle T, Barbosa HS Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL/6 mice. Micron 2008, 39:1335-1341.
12. Jones LA, Roberts CW Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol 2006, 28:635-642.
13. Gajewski TF, Fitch FW Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988, 140:4245-4252.
14. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 2001, 167:4574-4584.
15. Rozenfeld C, Martinez R, Seabra S, Sant'anna C, Goncalves JG, Bozza M Toxoplasma gondii prevents neuron degeneration by interferon-γ-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-β1 production by infected microglia. Am J Pathol 2005, 167:1021-1031.
16. Yap G, Pesin M, Sher A Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol 2000, 165:628-631.
17. Walker W, Roberts CW, Ferguson DJP, Jebbari H, Alexander J Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production. Infect Immun 1997, 65:1119-1121.
18. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol 2000, 164:5375-5382.
19. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 2005, 165:63-74.
20. Khan IA, Matsuura T, Kasper LH Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun 1994, 62:1639-1642.
21. Neyer LE, Gruniq G, Fort M Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun 1997, 65:1675-1682.
22. Aldebert D, Durand F, Mercier C, Brenier-Pinchart MP, Cesbron-Delauw MF, Pelloux H Toxoplasma gondii triggers secretion of interleukin-12 but low level of interleukin-10 from the THP-1 human monocytic cell line. Cytokine 2007, 37:206-211.
23. Denkers EY, Gazzinelli RT Regulation and function of T-cellmediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998, 11:569-588.
24. Appelberg R, Orme I, Pinto de Souza M, Silva M In vitro effects of interleukin-4 on interferon-gamma induced macrophage activation. Immunol 1992, 76:553-559.
25. Villard O, Candolfi E, Despringre J, et al. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Immunol 1995, 17:233-236.
26. Langermans JA, Nibbering PH, Van Vuren-Van Der Hulst ME, Van Furth R Transforming growth factor-beta supresses interferon-gamma induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production. Parasite Immunol 2001, 23:169-175.